Treatment of migraine attacks with a long-acting somatostatin analogue (octreotide, SMS 201-995)

Cephalalgia

Volumn 17, Issue 1, 1997, Pages 27-30

  Kapicioglu S ^a   Gokce E ^b   Kapicioglu Z ^a   Ovali, E ^a  

^a BLACK SEA TECHNICAL UNIVERSITY   (Turkey)

^b Social Security Hospital   (Turkey)

Author keywords

migraine; octreotide; somatostatin

Indexed keywords

BRADYKININ; OCTREOTIDE; PROSTAGLANDIN; SEROTONIN; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADULT; ANALGESIA; ARTICLE; BLOOD BRAIN BARRIER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEADACHE; HUMAN; MALE; MIGRAINE; PAIN; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; DOUBLE-BLIND METHOD; FEMALE; HORMONES; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; OCTREOTIDE; SEVERITY OF ILLNESS INDEX; SOMATOSTATIN;

EID: 0031040210     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.1997.1701027.x     Document Type: Article

References (23)

1. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8 Suppl 7:1-96
2. Lance JW, Lambert GA, Goadsby PJ, Zagami AS. 5-Hydroxy-tryptamine and its putative aetiological involvement in migraine. Cephalalgia 1989; Suppl 9:7-13
3. Parantainen J, Vapaatolo H. Prostaglandins in the pathophysiology of migraine. In: Curtis PB-Prior, editors. Prostaglandins: biology and chemistry of prostaglandins and related eicosanoids. Edinburgh/London: Churchill Livingstone, 1988: 386-410
4. Sicuteri F. Vasoneuroactive substances and their implication in vascular pain. Res Clin Stud Headache 1967;1:6-45
5. Sicuteri F, Renzi D, Geppetti P. Substance P and enkephalins: a creditable tandem in the pathophysiology of cluster headache and migraine. Adv Exp Med Biol 1986;198:145-52
6. Goadsby PJ. Facial nerve stimulation causes local release of vasoactive intestinal polypepridespeptide in the cat cortex. In: Seylaz J, Mackenzie ET, editors. Neurotransmission and cerebrovascular function 1989;1:325-8
7. Reichlin S. Somatostatin. N Engl J Med 1983;309:1495-501
8. Patel Y, Zings II, Fitzpatric D, Srikant C. Somatostatin: some aspects of its physiology. In: Bloom S, Polak J, editors. Gut hormones. Edinburgh: Churchill Livingstone, 1986
9. Chiba T, Yamada T. Gut Somatostatin. In: Walsh J, Dockray G, Martini L, editors. Gut peptides, comprehensive endocrinology. New York: Raven Press, 1994:123-45
10. Gyr KE, Meier R. Pharmacodynamic effects of Somatostatin in gastrointestinal tract. Digestion 1993;54:14-9
11. Kvols LK, Moertel CG, O'Cannel MJ, Schutt AJ, Rubin J, Hahn RG. Treatment of the malignant carcinoid syndrome. N Engl J Med 1986;315:663-6
12. Debas HT, Gittes G. Somatostatin analogue therapy functioning neuroendocrine gut tumor. Digestion 1993;54:68-71
13. Tolis G. Long-term management of acromegaly with sandostatin. Horm Res 1988;29:112-4
14. Bennett-Clark C, Romagnano M, Joseph S. Distribution of Somatostatin in the rat brain: telencephalon and diencephalon. Brain Res 1988;188:473-86
15. Richter G, Stöckmann F, Lembcke B, Conlon JM, Creutzfeldt W. Short-term administration of the Somatostatin analogue SMS 201-995 in patients with carcinoid tumors. Scand J Gastroenterol 1986;21:193-8
16. Ferrar JA, Cuthbert AW, Cox HM. The antisecretory effects of Somatostatin and analogues in rat descending colon mucosa. Eur J Pharmacol 1990;184:295-303
17. Yoshioka M, Sakazume M, Fukagawa M, et al. A case of the watery diarrhea hypokalemia-achlorhydria diarrhea with a somatostatin analogue. Jap J Clin Oncol 1989;19:294-8
18. Fassler JE, O'Dorisio TM, Mekhjian HS, Gaginella TS. Octreotide inhibits increases in short-circuit current induced in rat colon by VIP, Substance-P, serotonin and aminophylline. Reg Pept 1990;29:189-97
19. The Finnish Sumatriptan Group and the Cardiovascular Research Group. A placebo-controlled study of intranasal sumatriptan for the acute treatment of migraine. Eur Neurol 1991;31:332-8
20. Tisco P, Adler M, Liu-Chen L-Y. Differential release of substance-P and somatostatin in rat spinal cord in response to noxious cold and heat: effect of dynorphin A. J Pharm Exp Ther 1990;252:539-45
21. Chrubasik J, Bonath K, Cramer H, Rissler K, Wunsch E. Permeability of epidural somatostatin and morphine into the intrathecal space of dogs. Regul Pept 1986;13:119-24
22. Kroin JS, O'Dorisio TM, Penn RD, Haklin MF, Howe BA. Distribution of a somatostatin analog after continuous intraventricular administration. Neurosurgery 1989;24:744-8
23. Banks WA, Schally AV, Barrera CM, Fasold MB, Durham DA, Chernus VJ, et al. Permeability of the murine blood-brain barrier to some octapeptide analogs of somatostatin. Proc Natl Acad Sci USA 1990;87:6762-6